These genes have been implicated in insulin resistance and glycemic control in previous studies, and their joint prioritization in insulin-responsive tissues provides a plausible, though still indirect, link between the modest HbA1c improvement observed in our trial and potential effects of DDG on insulin-related pathways. This evidence concerns the gene INS and Insulin resistance.